MBB Public Markets I LLC Buys Shares of 1,508 Danaher Corporation $DHR

Key Points

• MBB Public Markets I LLC acquired 1,508 shares of Danaher Corporation (NYSE:DHR) in Q1, valued at approximately $309,000.
• Danaher's quarterly earnings surpassed analysts' expectations with an EPS of $1.80 vs. a consensus estimate of $1.64, and revenue reached $5.94 billion.
• Seventeen analysts currently have a Buy rating for Danaher, with a consensus target price of $246.35 for the stock.

MBB Public Markets I LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,508 shares of the conglomerate's stock, valued at approximately $309,000.

Several other large investors have also modified their holdings of DHR. Bank Pictet & Cie Europe AG boosted its position in shares of Danaher by 22.8% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock valued at $44,241,000 after buying an additional 35,730 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Danaher by 7.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 63,534 shares of the conglomerate's stock valued at $14,584,000 after buying an additional 4,388 shares during the period. Obermeyer Wealth Partners boosted its position in shares of Danaher by 25.6% during the fourth quarter. Obermeyer Wealth Partners now owns 2,012 shares of the conglomerate's stock valued at $462,000 after buying an additional 410 shares during the period. Numerai GP LLC purchased a new position in shares of Danaher during the fourth quarter valued at approximately $1,983,000. Finally, Nuveen Asset Management LLC raised its stake in shares of Danaher by 2.8% during the fourth quarter. Nuveen Asset Management LLC now owns 4,068,948 shares of the conglomerate's stock valued at $934,027,000 after acquiring an additional 111,894 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research note on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Barclays reaffirmed an "overweight" rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $246.35.

Danaher Stock Performance

Shares of NYSE:DHR opened at $192.85 on Thursday. The company has a market capitalization of $138.09 billion, a price-to-earnings ratio of 41.03, a price-to-earnings-growth ratio of 2.71 and a beta of 0.75. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a 50 day moving average of $201.62 and a 200 day moving average of $199.15.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. Danaher's payout ratio is 27.23%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.